Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study

Gaurav Narula¹, Swaminathan Keerthivasagam^{2

3}, Hasmukh Jain⁴, Sachin Punatar⁵, Akanksha Chichra⁵, Chetan Dhamne², Prashant Tembhare⁶, Papagudi Ganesan Subramanian⁶, Nikhil Patkar⁶, Minal Poojary⁷, Anant Gokarn⁵, Sumeet Mirgh⁵, Nishant Jindal⁵, Albeena Nisar⁸, Deepali Pandit⁹, Khushali Pandit⁹, Alka Dwivedi^{10

11}, Atharva Karulkar^{10

12}, Ankesh Kumar Jaiswal¹⁰, Aalia Khan¹⁰, Shreshtha Shah¹², Afrin Rafiq¹⁰, Moumita Basu¹², Juber Pendhari¹⁰, Sweety Asija¹⁰, Ambalika Chowdury¹⁰, Ankit Banik¹⁰, Nirmalya Roy Moulik², Shyam Srinivasan², Shilpushp Bhosle¹³, Sumathi Hiregoudar⁷, Shashank Ojha⁷, Lingaraj Nayak⁴, Jayshree Thorat⁴, Bhausaheb Bagal⁴, Manju Sengar⁴, Navin Khattry⁵, Shripad Banavali¹⁴, Steven Highfill¹⁵, Nirali N Shah¹¹, Rahul Purwar^{10

12}

Affiliations

¹ Department of Pediatric Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. drgauravnarula@gmail.com.
² Department of Pediatric Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
³ Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
⁴ Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
⁵ Bone marrow transplant unit, Department of Medical Oncology, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute, Mumbai, India.
⁶ Department of Hematopathology, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute, Navi Mumbai, India.
⁷ Department of Transfusion Medicine, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute, Navi Mumbai, India.
⁸ Scientific Officer (D), CAR-T and Cell Therapy Centre, ACTREC, Tata Memorial Centre, Mumbai, India.
⁹ CAR-T and Cell Therapy Centre, ACTREC, Tata Memorial Centre, Kharghar, India.
¹⁰ Department of Biosciences & Bioengineering, Indian Institute of Technology Bombay, Mumbai, India.
¹¹ Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
¹² Immunoadoptive Cell Therapy Private Limited (ImmunoACT), Mumbai, India.
¹³ Department of Critical Care and Anaesthesiology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
¹⁴ Director Academics and Professor Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
¹⁵ Center for Cellular Engineering, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

PMID: 40393961
PMCID: PMC12092698
DOI: 10.1038/s41408-025-01308-7

Published Erratum

Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study

Gaurav Narula et al. Blood Cancer J. 2025.

. 2025 May 20;15(1):98.

doi: 10.1038/s41408-025-01308-7.

Authors

Affiliations

¹ Department of Pediatric Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. drgauravnarula@gmail.com.
² Department of Pediatric Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
³ Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
⁴ Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
⁵ Bone marrow transplant unit, Department of Medical Oncology, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute, Mumbai, India.
⁶ Department of Hematopathology, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute, Navi Mumbai, India.
⁷ Department of Transfusion Medicine, Tata Memorial Centre, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute, Navi Mumbai, India.
⁸ Scientific Officer (D), CAR-T and Cell Therapy Centre, ACTREC, Tata Memorial Centre, Mumbai, India.
⁹ CAR-T and Cell Therapy Centre, ACTREC, Tata Memorial Centre, Kharghar, India.
¹⁰ Department of Biosciences & Bioengineering, Indian Institute of Technology Bombay, Mumbai, India.
¹¹ Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
¹² Immunoadoptive Cell Therapy Private Limited (ImmunoACT), Mumbai, India.
¹³ Department of Critical Care and Anaesthesiology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
¹⁴ Director Academics and Professor Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.
¹⁵ Center for Cellular Engineering, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

PMID: 40393961
PMCID: PMC12092698
DOI: 10.1038/s41408-025-01308-7

No abstract available

PubMed Disclaimer

Erratum for

Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.
Narula G, Keerthivasagam S, Jain H, Punatar S, Chichra A, Dhamne C, Tembhare P, Subramanian PG, Patkar N, Poojary M, Gokarn A, Mirgh S, Jindal N, Nisar A, Pandit D, Pandit K, Dwivedi A, Karulkar A, Jaiswal AK, Khan A, Shah S, Rafiq A, Basu M, Pendhari J, Asija S, Chowdury A, Banik A, Moulik NR, Srinivasan S, Bhosle S, Hiregoudar S, Ojha S, Nayak L, Thorat J, Bagal B, Sengar M, Khattry N, Banavali S, Highfill S, Shah NN, Purwar R. Narula G, et al. Blood Cancer J. 2025 Apr 24;15(1):75. doi: 10.1038/s41408-025-01279-9. Blood Cancer J. 2025. PMID: 40274761 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study

Affiliations

Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources